NCT05224115View on ClinicalTrials.gov

Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

October 13, 2020

Study Completion Date

October 13, 2020

Conditions
Huntington Disease
Interventions
OTHER

[11C]CHDI-00485180-R

Mutant huntingtin aggregate binding PET radioligand.

OTHER

[11C]CHDI-00485626

Mutant huntingtin aggregate binding PET radioligand.

Trial Locations (1)

3000

UZ Leuven, Leuven

All Listed Sponsors
collaborator

CHDI Foundation, Inc.

OTHER

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT05224115 - Dosimetry of [11C]CHDI-180R and [11C]CHDI-626. | Biotech Hunter | Biotech Hunter